Geneva Advisors’s CDK Global, Inc. CDK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$798K Buy
12,854
+9,454
+278% +$593K 0.01% 410
2017
Q1
$221K Sell
3,400
-162
-5% -$10.4K ﹤0.01% 662
2016
Q4
$213K Sell
3,562
-2,349
-40% -$134K ﹤0.01% 664
2016
Q3
$339K Buy
5,911
+105
+2% +$6.04K 0.01% 550
2016
Q2
$322K Sell
5,806
-33
-0.6% -$1.71K 0.01% 539
2016
Q1
$272K Hold
5,839
0.01% 560
2015
Q4
$277K Sell
5,839
-1,689
-22% -$82K 0.01% 520
2015
Q3
$360K Buy
7,528
+1,294
+21% +$65.7K 0.01% 446
2015
Q2
$337K Buy
+6,234
New +$320K 0.01% 501

Other funds holding CDK

Geneva Advisors's CDK Position: Q2 2017 in Review

Geneva Advisors increased its CDK Global, Inc. (CDK) stake by 278% in Q2 2017, buying an estimated $593K and bringing the position to 12,854 shares worth $798K. The position accounts for 0.01% of the portfolio, ranked #410.

Geneva Advisors first reported a position in CDK in Q2 2015 and has held it in 9 quarters since. 571 funds tracked by Wall St. Rank hold CDK as of Q2 2017.

  • Geneva Advisors held 12,854 shares of CDK Global, Inc. worth $798K as of Q2 2017.
  • Geneva Advisors bought 9,454 CDK Global, Inc. shares in Q2 2017, an estimated $593K.
  • CDK Global, Inc. made up 0.01% of Geneva Advisors's portfolio in Q2 2017, its #410 holding.
  • Geneva Advisors first reported a position in CDK Global, Inc. in Q2 2015 and has held it in 9 quarters since.
  • 571 funds tracked by Wall St. Rank held CDK Global, Inc. as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.